Latest News & Updates

Breaking News

  • 1 hour ago

  • Pharma Now Editorial Team

First NBD1 Stabilizer Enters Phase 2a Proof-of-Concept Readout
Breaking News
Vohra's Move to Cohance Signals CDMO Sector's Executive Ambitions

Pharma Now Editorial Team

Other trending news you may like to read

First NBD1 Stabilizer Enters Phase 2a Proof-of-Concept Readout

Sionna completes PreciSION CF Phase 2a enrollment; SION-719 topline data expected summer 2026.

Pharma Now Editorial Team

Pharma Now

Vohra's Move to Cohance Signals CDMO Sector's Executive Ambitions

Umang Vohra joins Cohance Lifesciences as Executive Chairman and Group CEO as Vivek Sharma moves to advisory role.

Pharma Now Editorial Team

Pharma Now

Cipla Lands First AB-Rated Generic for Ventolin HFA

Cipla receives USFDA approval for the first AB-rated generic of Ventolin HFA, marking a significant advance in complex inhaler generics.

Pharma Now Editorial Team

Pharma Now

Medicus Pharma Takes SkinJect Orphan Push to Capitol Hill

Medicus Pharma met with House Energy and Commerce leaders to advance Orphan Drug Designation and registrational IND approval for SkinJect in Gorlin Syndrome.

Pharma Now Editorial Team

Pharma Now